Fecal Microbiota Transplantation

The first time I heard about “stool transplant” was in the late 1990s when I was attending a regional winter meeting of gastroenterologists in Brainerd, Minnesota (ironically, the site of an unexplained but well-documented outbreak of chronic diarrhea in the 80s).

Fecal microbiota transplantation is safe in patients with psoriatic arthritis, according to data from the first preliminary, randomized trial of the procedure in immune-mediated arthritis.

ACG developed guidelines for the preferred management of adults with Clostridioides difficile infection, published in the American Journal of Gastroenterology.

MicroRNAs showed that fecal microbiota transplants are effective for treating infections like Clostridioides difficile infection, according to a study published in Gastroenterology.

Healio Gastroenterology presents the following reports on the most recent research on COVID-19 is gastrointestinal conditions.

In this exclusive video, Jessica Allegretti, MD, MPH, director of the fecal microbiota center at Brigham and Women’s Hospital, discusses how FMT has transformed treatment in a number of GI conditions.

A new study showed that fecal microbiota transplantation appeared to be safe and effective against Clostridioides difficile infection during a 2-year follow-up period. It was the top story in gastroenterology last week.

Fecal microbiota transplantation appeared safe with low risk for transmission of infection in patients with recurrent Clostridioides difficile infection, according to study results.

Fecal microbiome transfer led to a mean reduction in android-to-gynoid fat ratio and a resolution of metabolic syndrome in a cohort of adolescents with obesity, according to randomized controlled trial data published in JAMA Network Open.

In this exclusive video, Jessica Allegretti, MD, MPH, discussed the use of fecal microbiota transplantation to treat Clostridioides difficile infection in inflammatory bowel disease, IBD alone and to treat patients with J-pouches.